54 101 Pill - orange round, 6mm
Pill with imprint 54 101 is Orange, Round and has been identified as Bosentan Monohydrate 62.5 mg. It is supplied by Hikma Pharmaceuticals PLC.
Bosentan is used in the treatment of Pulmonary Arterial Hypertension and belongs to the drug class agents for pulmonary hypertension. Not for use in pregnancy. Bosentan 62.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 101
Bosentan Monohydrate
- Imprint
- 54 101
- Strength
- 62.5 mg
- Color
- Orange
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Agents for pulmonary hypertension
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceuticals PLC
- National Drug Code (NDC)
- 00054-0520 (Discontinued)
See also:
Cialis
Cialis (tadalafil) increase increases blood flow to a certain area of the body and is used to treat ...
Viagra
Viagra (sildenafil) is used to treat erectile dysfunction or impotence in men. Includes Viagra side ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Adcirca
Adcirca is used to treat pulmonary arterial hypertension. Learn about side effects, interactions ...
Opsumit
Opsumit (macitentan) is used to treat pulmonary arterial hypertension. Includes Opsumit side ...
Revatio
Revatio (sildenafil) is used to treat pulmonary arterial hypertension. Includes Revatio side ...
Adempas
Adempas (riociguat) is used to treat pulmonary hypertension. Includes Adempas side effects ...
Winrevair
Winrevair (sotatercept) is an injectable activin signaling inhibitor that can be self-administered ...
More about bosentan
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.